Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve unaudited financial results for quarter and half year ended September 30, 2026.

October 22, 2026 To To The Secretary The Secretary National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Trading Symbol: DIVISLAB Scrip Code: 532488 Dear Sir / Madam, Sub: Intimation of Board Meeting Ref: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 We hereby inform that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, November 07, 2026, inter-alia to consider and approve unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2026. As intimated earlier on September 30, 2026, the Trading Window for dealing in securities of the Company has been closed from October 01, 2026 till 48 hours after the declaration of financial results. Thus, the Trading window shall remain closed till November 09, 2026. This is for your information and records. Thanking You, Yours faithfully, For Divi's Laboratories Limited M. Satish Choudhury Company Secretary & Compliance Officer